 Establishment Labs Holdings Inc. ESTA, a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced preliminary financial results for the fourth quarter and full year 2019, with total revenue growth for the quarter of 43 to 49. 2019 was another extraordinary year for Establishment Labs, and we ended the year on a strong note with our sixth consecutive quarter of record revenue performance, said Juan José Chacón-Quirós, Founder and CEO of Establishment Labs. Preliminary and unaudited revenue for the fourth quarter of 2019 is expected to be in the range of 23.5 million and 24.5 million, representing growth of approximately 43 to 49 over the fourth quarter of 2018. 